239 related articles for article (PubMed ID: 10903442)
1. Mouse NRH:quinone oxidoreductase (NQO2): cloning of cDNA and gene- and tissue-specific expression.
Long DJ; Jaiswal AK
Gene; 2000 Jul; 252(1-2):107-17. PubMed ID: 10903442
[TBL] [Abstract][Full Text] [Related]
2. Human NAD(P)H:quinone oxidoreductase2. Gene structure, activity, and tissue-specific expression.
Jaiswal AK
J Biol Chem; 1994 May; 269(20):14502-8. PubMed ID: 8182056
[TBL] [Abstract][Full Text] [Related]
3. Nucleotide and deduced amino acid sequence of a human cDNA (NQO2) corresponding to a second member of the NAD(P)H:quinone oxidoreductase gene family. Extensive polymorphism at the NQO2 gene locus on chromosome 6.
Jaiswal AK; Burnett P; Adesnik M; McBride OW
Biochemistry; 1990 Feb; 29(7):1899-906. PubMed ID: 1691923
[TBL] [Abstract][Full Text] [Related]
4. NRH:quinone oxidoreductase2 (NQO2).
Long DJ; Jaiswal AK
Chem Biol Interact; 2000 Dec; 129(1-2):99-112. PubMed ID: 11154737
[TBL] [Abstract][Full Text] [Related]
5. NAD(P)H:quinone oxidoreductase 1 and nrh:quinone oxidoreductase 2 activity and expression in bladder and ovarian cancer and lower NRH:quinone oxidoreductase 2 activity associated with an NQO2 exon 3 single-nucleotide polymorphism.
Jamieson D; Wilson K; Pridgeon S; Margetts JP; Edmondson RJ; Leung HY; Knox R; Boddy AV
Clin Cancer Res; 2007 Mar; 13(5):1584-90. PubMed ID: 17332305
[TBL] [Abstract][Full Text] [Related]
6. Regulation of genes encoding NAD(P)H:quinone oxidoreductases.
Jaiswal AK
Free Radic Biol Med; 2000 Aug; 29(3-4):254-62. PubMed ID: 11035254
[TBL] [Abstract][Full Text] [Related]
7. Genomic organization and promoter analysis of the mouse ADP-ribosylarginine hydrolase gene.
Aoki K; Kato J; Shoemaker MT; Moss J
Gene; 2005 May; 351():83-95. PubMed ID: 15893437
[TBL] [Abstract][Full Text] [Related]
8. AP-2-mediated regulation of human NAD(P)H: quinone oxidoreductase 1 (NQO1) gene expression.
Xie T; Jaiswal AK
Biochem Pharmacol; 1996 Mar; 51(6):771-8. PubMed ID: 8602872
[TBL] [Abstract][Full Text] [Related]
9. Mouse dioxin-inducible NAD(P)H: menadione oxidoreductase: NMO1 cDNA sequence and genetic differences in mRNA levels.
Vasiliou V; Theurer MJ; Puga A; Reuter SF; Nebert DW
Pharmacogenetics; 1994 Dec; 4(6):341-8. PubMed ID: 7704040
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the mouse liver fructose-1,6-bisphosphatase gene.
Stein S; Liehr T; Eschrich K
Gene; 2001 Feb; 264(2):215-24. PubMed ID: 11250076
[TBL] [Abstract][Full Text] [Related]
11. Coordinated induction of the c-jun gene with genes encoding quinone oxidoreductases in response to xenobiotics and antioxidants.
Radjendirane V; Jaiswal AK
Biochem Pharmacol; 1999 Aug; 58(4):597-603. PubMed ID: 10413296
[TBL] [Abstract][Full Text] [Related]
12. Association analyses between polymorphisms of the phase II detoxification enzymes (GSTM1, NQO1, NQO2) and alcohol withdrawal symptoms.
Okubo T; Harada S; Higuchi S; Matsushita S
Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):68S-71S. PubMed ID: 12960511
[TBL] [Abstract][Full Text] [Related]
13. Reduction and Scavenging of Chemically Reactive Drug Metabolites by NAD(P)H:Quinone Oxidoreductase 1 and NRH:Quinone Oxidoreductase 2 and Variability in Hepatic Concentrations.
den Braver-Sewradj SP; den Braver MW; Toorneman RM; van Leeuwen S; Zhang Y; Dekker SJ; Vermeulen NPE; Commandeur JNM; Vos JC
Chem Res Toxicol; 2018 Feb; 31(2):116-126. PubMed ID: 29281794
[TBL] [Abstract][Full Text] [Related]
14. Catalytic properties of NAD(P)H:quinone oxidoreductase-2 (NQO2), a dihydronicotinamide riboside dependent oxidoreductase.
Wu K; Knox R; Sun XZ; Joseph P; Jaiswal AK; Zhang D; Deng PS; Chen S
Arch Biochem Biophys; 1997 Nov; 347(2):221-8. PubMed ID: 9367528
[TBL] [Abstract][Full Text] [Related]
15. Structural characterization and chromosomal localization of the mouse cDNA and gene encoding the bone tyrosine phosphatase, mOST-PTP.
Morrison DF; Mauro LJ
Gene; 2000 Oct; 257(2):195-208. PubMed ID: 11080586
[TBL] [Abstract][Full Text] [Related]
16. NAD(P)H: quinone oxidoreductase 1 and NRH:quinone oxidoreductase 2 polymorphisms in papillary thyroid microcarcinoma: correlation with phenotype.
Lee J; Kim KS; Lee MH; Kim YS; Lee MH; Lee SE; Kim YK; Ryu MJ; Kim SJ; Choi MJ; Jo YS
Yonsei Med J; 2013 Sep; 54(5):1158-67. PubMed ID: 23918565
[TBL] [Abstract][Full Text] [Related]
17. Gene structure and expression of phospholemman in mouse.
Bogaev RC; Jia LG; Kobayashi YM; Palmer CJ; Mounsey JP; Moorman JR; Jones LR; Tucker AL
Gene; 2001 Jun; 271(1):69-79. PubMed ID: 11410367
[TBL] [Abstract][Full Text] [Related]
18. Human NAD(P)H:quinone oxidoreductase (NQO1) gene structure and induction by dioxin.
Jaiswal AK
Biochemistry; 1991 Nov; 30(44):10647-53. PubMed ID: 1657151
[TBL] [Abstract][Full Text] [Related]
19. Differential gene expression of NAD(P)H:quinone oxidoreductase and NRH:quinone oxidoreductase in human hepatocellular and biliary tissue.
Strassburg A; Strassburg CP; Manns MP; Tukey RH
Mol Pharmacol; 2002 Feb; 61(2):320-5. PubMed ID: 11809856
[TBL] [Abstract][Full Text] [Related]
20. Sp3 repression of polymorphic human NRH:quinone oxidoreductase 2 gene promoter.
Wang W; Jaiswal AK
Free Radic Biol Med; 2004 Oct; 37(8):1231-43. PubMed ID: 15451063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
